Aldose reductase: a novel therapeutic target for inflammatory pathologies

KV Ramana, SK Srivastava - The international journal of biochemistry & …, 2010 - Elsevier
Aldose reductase (AR), that catalyzes the rate limiting step of the polyol pathway of glucose
metabolism, besides reducing glucose to sorbitol, reduces a number of lipid peroxidation …

[HTML][HTML] Physiological and pathological roles of aldose reductase

M Singh, A Kapoor, A Bhatnagar - Metabolites, 2021 - mdpi.com
Aldose reductase (AR) is an aldo-keto reductase that catalyzes the first step in the polyol
pathway which converts glucose to sorbitol. Under normal glucose homeostasis the pathway …

From a dull enzyme to something else: facts and perspectives regarding aldose reductase

AD Corso, M Cappiello, U Mura - Current Medicinal Chemistry, 2008 - ingentaconnect.com
Aldose Reductase (ALR2) is defined as the first enzyme of the “polyol pathway”. As such,
ALR2 would convert glucose to sorbitol through an NADPH dependent reaction. Considered …

Recent studies of aldose reductase enzyme inhibition for diabetic complications

S Suzen, E Buyukbingol - Current medicinal chemistry, 2003 - ingentaconnect.com
Aldose reductase [ALR2; EC 1.1. 1.21], a key enzyme of polyol pathway, catalyzes NADPH-
dependent reduction of glucose to sorbitol (Sorbitol pathway), and an excessive …

Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions

R Maccari, R Ottanà - Journal of medicinal chemistry, 2015 - ACS Publications
Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an
enzyme crucially involved in the pathogenesis of chronic complications associated with …

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options

SK Srivastava, KV Ramana, A Bhatnagar - Endocrine reviews, 2005 - academic.oup.com
Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme. The reduction
of glucose by the AR-catalyzed polyol pathway has been linked to the development of …

A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases

S Pandey, SK Srivastava… - Expert Opinion on …, 2012 - Taylor & Francis
Introduction: Aldose reductase (AR) was initially thought to be involved in the secondary
diabetic complications because of its glucose-reducing potential. However, evidence from …

Aldose reductase enzyme and its implication to major health problems of the 21st century

P Alexiou, K Pegklidou, M Chatzopoulou… - Current medicinal …, 2009 - ingentaconnect.com
Aldose reductase enzyme (ALR2) of the polyol metabolic pathway, apart from its role as
detoxifying enzyme towards toxic aldehydes, osmoregulator in the kidney and regulator of …

Aldose reductase: new insights for an old enzyme

KV Ramana - 2011 - degruyter.com
In the past years aldose reductase (AKR1B1; AR) is thought to be involved in the
pathogenesis of secondary diabetic complications such as retinopathy, neuropathy …

Aldose reductase inhibitors from the nature

K Kawanishi, H Ueda… - Current Medicinal …, 2003 - ingentaconnect.com
Aldose reductase (AR) is an NADPH-dependent enzyme that catalyses the reduction of the
aldehyde to the corresponding alcohols. Diabetic complications including neuropathy …